Wyglada, ze laboratorium Bowen z Florydy albo zostalo zamkniete, albo przestalo zajmowac sie borelioza.
Zamiast tego tzw Bowen test czy tez jakas kolejna jego wersja staje sie dostepna w nowym laboratorium na Florydzie - nazwa testu to 'cytometria przeplywowa'.
Znakowane przeciwciala sa dodane do krwi pacjenta i potem maszyna wychwytuje wszystkie miejsca gdzie p/cialo zwiazalo sie z antygenem. Wynik jest w procentach i im wyzszy procent tym wyzsze prawdopodobienstwo ze pacjent ma borelioze. Czyli pacjent nie musi miec wytworzonych przeciwcial by ten test wyszedl dodatnio.
Wiarygodnosc testu jest na tym etapie sprawa otwarta.
Ponizej notka prasowa. Internetowa strona laboratorium podobno jeszcze nie w pelni funkcjonalna.
USING 21st CENTURY TECHNOLOGY
CAPTURES THE LYME DISEASE ANTIGEN
IN A ONE OF A KIND TEST
Contact Person: Tom Long, Administrator
Central Florida Research, Inc.
245 N Seminole Avenue
Lake Alfred, Florida 33850
Phone: (863) 956-3538
FAX: (863) 956-0839
* Borrelia burgdorferi Direct Fluorescent Antibody by Flow Cytometer *
The Central Florida Research laboratory is located in Lake Alfred,
Florida and is replacing the laboratory operations of the Bowen
Research and Training Institute, Inc. Central Florida Research, Inc.
is a state licensed CLIA approved laboratory and is dedicated to the
research of Lyme disease and other (CSID) Chronic, Systemic,
Infectious Diseases. The Bowen Technique is still a viable part of
Bowen Research & Training Institute, Inc.
Antigen tests detect the organism itself and, unlike antibody tests,
antigen tests aren't dependent upon a `sick' immune system to produce
antibodies. The Central Florida Research laboratory in Lake Alfred,
Florida is doing antigen testing. CFR's antigen test is a one of a
kind. It is a direct fluorescent antibody test using a special kind
of technique called Flow Cytometry. This Flow Cytometer is a specific
instrument designed to identify bacteria 50,000 events are counted
in one minute and the number of bacteria reacting with the Borrelia
burgdorferi fluorescent antibody are enumerated in a diluted blood
specimen and reported as a percent.
The Flow Cytometer enumerates fluorescing events. The results are
expressed as ≤0.02% negative - 0.03% borderline -≥0.04 positive. The
Borrelia burgdorferi Direct Fluorescent Antibody by Flow Cytometer
test is the most definitive test of its kind available today. Since
Borrelia burgdorferi is a spirochete, an antigen test is more accurate
in detecting its presence in the blood than a test detecting
antibodies.. The Flow Cytometry test from Central Florida Research is
most beneficial in detecting Borrelia burgdorferi the causative agent
for Lyme disease.
Understanding the microbiology behind the spirochete and cyst form of
Borrelia burgdorferi and its ability to hide from our immune system,
helps us understand the Lyme Disease controversies and the
complications for testing for the bacteria. If the antibodies a
person's body normally produces against an invading pathogen aren't
always present, then we must have a test that detects the antigen.
However, the antibody test(s) are accurate. If an antibody is
developed, the test will detect it. Patients with Lyme disease do not
always develop antibodies. The antibodies may disappear over a period
of time. Testing for the spirochetes in blood presents a problem
because spirochetes may be present in such minute numbers that it is
difficult to get a sample with the spirochete present. The antigen
test detects the spirochete as a spirochete or cyst. If the test is
negative by Flow Cytometry, it does not mean that the patient does not
have Lyme disease. The spirochete may not be present in the sample of
blood collected or the number may be too small and the amount tested
did not detect the microorganism. Symptoms are still the physician's
greatest diagnostic tool, when used in conjunction with clinical testing.
Since Borrelia burgdorferi Direct Fluorescent Antibody by Flow
Cytometry is an antigen test, the result is more accurate in
detecting its presence in the blood than a test for antibodies.